About Me
I am a PhD student in Economics at Aalto University. My research is in industrial organization, with a focus on collusion and pharmaceutical markets.
I will be on the 2026/2027 job market.
Job market paper
Tacit Collusion in the Finnish Pharmaceutical Market with Matias Pousi
Show Abstract
We study how regulation can facilitate tacit collusion through focal pricing in the Finnish pharmaceutical market. Under the reference pricing system, firms repeatedly set prices relative to a publicly observed benchmark, creating a natural focal point for coordination. Using detailed product-level data, we document systematic price increases equal to the size of the regulated price band and show that many firms align their prices with the previous quarter’s reference price. To rationalize these patterns, we develop a structural model of competition between generic firms and a potential parallel importer. In the model, incumbent firms choose whether to increase prices or maintain current prices, while a parallel importer decides whether to enter given prevailing price levels. Estimation results indicate that higher prices increase the likelihood of entry, which in turn disciplines collusive behavior. Counterfactual analysis shows that reducing the price band from 0.5 to 0.1 euros substantially increases entry probabilities and reduces collusion incentives, while larger price bands facilitate coordination. Our findings highlight a novel channel through which regulation may unintentionally promote coordinated outcomes by creating focal pricing rules.Working papers
Competition or Collusion? Entry Decisions in the Swedish Pharmaceutical Market with Otto Toivanen
Show Abstract
Observing different firms having a monopoly position in parts of a market may be the result of either intense post-entry competition and non-cooperative entry decisions, or collusive entry. This phenomenon and large price differences per pill are wide-spread in the Swedish pharmaceutical market where monthly auctions for each active ingredient-dosage form-strength-package size combination channel a large part of demand to the winner. 22% of the markets are potentially collusive at least some of the time and prices in such markets are significantly higher per pill. We take a structural model tailored to the Swedish circumstances to data on two markets. In one market, the entry patterns (monopoly package sizes) are suggestive of collusion, but not in the other. Our counterfactual analyses where we either remove monopoly package sizes or allow substitution across package sizes yield savings of 50-60% in both markets, with very small if any effects on demand.A Stylized Logit Demand Model with Internal Reference Pricing
Show Abstract
I study conditions for the existence and uniqueness of equilibrium in a logit model that incorporates an internal reference price and a copayment structure. Using the Intermediate Value Theorem, I prove equilibrium existence in a two‑product market and show that the equilibrium is unique under additional restrictions: the two firms must be sufficiently different so that their best‑response functions cross but do not overlap over an interval. I then extend the existence result to an $n$-product market with an aggregative‑game approach.Teaching Assistant
Math Camp, Ph.D. level: Aug 2024, Aug 2025
Empirical Industrial Organization, M.Sc. level: Oct 2024, Oct 2025
Principles of Economics, B.Sc. level: Sep 2022, Sep 2023, Sep 2024, Sep 2025
Intermediate Macroeconomics II, B.Sc. level: Mar 2023, Mar 2024, Mar 2025
Mathematics for Economists, B.Sc. level: Oct 2021